adalimumab

noun

ada·​lim·​u·​mab ˌād-ə-ˈlim-yu̇-ˌmab 

: an immunosuppressive drug that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis)

The labeling of adalimumab includes a boxed warning—the strongest type of label warning …

—ACP Medicine

Note: Adalimumab acts by binding to and blocking the activity of tumor necrosis factor. It is marketed under the trademark Humira.